|
|
|
|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
|
Weekly reads: oocytes from males, David Sinclair longevity inc, diabetes, He Jiankui
|
|
|
|
A team led by Harvard professor David Sinclair had a recent Cell paper on reprogramming to fight aging that I reviewed here on The Niche. I thought the paper was exciting and important. Note that in vivo reprogramming was first done more than a decade ago. Sinclair did have a novel fast-forward aging method and overall the data were impressive. However, …
|
|
|
|
|
|
|
|
Where Kimera Labs fits into sphere of exosome companies
|
|
|
|
Today's post takes a close look at the exosome manufacturer Kimera Labs in the context of the main exosome companies. What are exosomes? Exosomes are microscopic bubbles or vesicles produced by cells. Exosomes contain many cellular substances that are biologically active. Some of these materials may be helpful clinically, while others could pose risks. Clinical outcomes likely depend on a vast …
|
|
|
|
|
|
|
|
WHYY oh WHYY: NPR puff piece on risky stem cell microneedling
|
|
|
|
I usually associate NPR with solid journalism so I was scratching my head about a recent puff piece by WHYY on stem cell microneedling. Is this journalism or product promotion? The NPR piece by Maiken Scott doesn't ask important questions. Scott received stem cell microneedling herself using a product from a company called AnteAGE. How does that work? What's the deal …
|
|
|
|
|
|
